Weston Daniel

Company: EVOQ Therapeutics

Job title: Chief Development Officer

Seminars:

Exploring the Nanodisc Platform for the Induction of Antigen-Specific Immune Tolerance 11:30 am

• Developing a proprietary technology that can effectively stimulate dendritic cells to orchestrate immune responses • Manipulating dendritic cells to induce either immune activation or tolerance, depending on the stimulation they receive • Efficiently delivers antigens to lymph nodes, where dendritic cells are concentrated, enhancing the immune responseRead more

day: Custom Day Two